Papaverine Hydrochloride
PAPAVERINE HYDROCHLORIDE INJECTION, USP
Approved
Approval ID
5ba6e650-a5b5-4381-a62a-b7a6df73e8e6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 9, 2023
Manufacturers
FDA
Oryza Pharmaceuticals Inc.
DUNS: 080337493
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Papaverine Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72516-024
Product Classification
G
Generic Name
Papaverine Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 26, 2021
FDA Product Classification
INGREDIENTS (5)
PAPAVERINE HYDROCHLORIDEActive
Quantity: 30 mg in 1 mL
Code: 23473EC6BQ
Classification: ACTIB
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT